DHR
DANAHER CORP /DE/
NYSE: DHR · Washington, DC · Industrials
$188.41+4.88 (+2.66%)Closed
Market Cap$133.40B
Cash$5.69Bmost recent
Runwayprofitable
P/E (TTM)37.3EPS $5.05
52-Wk Range$161.91 – $241.54
Avg Volume4.1M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$188.41-28.0%
Pipeline
Drug candidates sponsored by DANAHER CORP /DE/ · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for DHR. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.